Recommended Topic Related To:
Busulfex
FDA Approves Iclusig for Rare Leukemia »
"The U.S. Food and Drug Administration today approved Iclusig (ponatinib) to treat adults with chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), two rare blood and bone marrow diseases.
"...Busulfex
PATIENT INFORMATION
The increased risk of a second malignancy should be explained to the patient.
Last reviewed on RxList: 8/5/2011
This monograph has been modified to include the generic and brand name in many instances.
Next: Drug Description
Additional Busulfex Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
